0001144204-14-066837.txt : 20141112 0001144204-14-066837.hdr.sgml : 20141111 20141112080106 ACCESSION NUMBER: 0001144204-14-066837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141110 FILED AS OF DATE: 20141112 DATE AS OF CHANGE: 20141112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 752308816 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 BUSINESS PHONE: 86-538-620-3897 MAIL ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shao Sean CENTRAL INDEX KEY: 0001432657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34566 FILM NUMBER: 141211175 MAIL ADDRESS: STREET 1: 21ST FLOOR, EVERBRIGHT BANK BUILDING STREET 2: ZHUZILIN, FUTIAN DISTRICT CITY: SHENZHEN, GUANGDONG STATE: F4 ZIP: 518040 4 1 v393929_4.xml FORM 4 X0306 4 2014-11-10 0 0001369868 China Biologic Products, Inc. CBPO 0001432657 Shao Sean 21ST FLOOR, EVERBRIGHT BANK BUILDING ZHUZILIN, FUTIAN DISTRICT SHENZHEN, GUANGDONG F4 100125 CHINA 1 0 0 0 Common stock 2014-11-10 4 M 0 40000 12.26 A 62500 D Common stock 2014-11-10 4 M 0 30000 16.39 A 92500 D Common stock 2014-11-10 4 S 0 40000 62.75 D 52500 D Common stock 2014-11-10 4 S 0 30000 62.75 D 22500 D Common stock 2014-11-10 4 S 0 2500 62.75 D 20000 D Stock Option (right to buy) 12.26 2014-11-10 4 M 0 40000 D 2010-10-11 2020-07-11 Common stock 40000 30000 D Stock Option (right to buy) 16.39 2014-11-10 4 M 0 30000 D 2011-04-01 2021-01-01 Common stock 30000 0 D Represents an aggregate of 70,000 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnotes 2 and 3 below for further details on the relevant stock options. Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated July 11, 2010. The options will vest in equal portions on a quarterly basis over a 3-year period, with the first portion to vest on October 11, 2010. Represents previously reported stock options to purchase 30,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated January 1, 2011. The options will vest in equal portions on a quarterly basis over a 12-month period, with the first portion to vest on April 1, 2011. /s/ Sean Shao 2014-11-12